Recon: Novo Nordisk to slash Wegovy price by as much as 37% in India; Neurocrine depression therapy fails in mid-stage study
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.In Focus: US
- The $10 billion question: Will Pfizer hit it big with Metsera, or have regrets? (STAT)
- What Pfizer’s Metsera deal means for biotech M&A (STAT)
- New Rules, New Risks: Inside the Changing World of Federal Inspections (FDA Law Blog)
- US Health Care Premium Spikes to Squeeze Main Street Businesses (Bloomberg)
- China’s biotech boom is being driven by a dazzling market rebound (STAT)
- U.K. releases plan to phase out animal testing in research (STAT)
- South Africa Starts Trial of First Self-Made Vaccine in 50 Years (Bloomberg)
- Novo Nordisk cuts Wegovy price by up to 37% in India (Reuters)
- India's JB Chemicals & Pharmaceuticals posts profit jump on strong domestic demand (Reuters)
- UNICEF says Israel blocking one million syringes needed to vaccinate Gaza children (Reuters)
- Merck’s pill to reduce cholesterol on top of statins matches results from injectables (STAT)
- EnGene posts more pivotal data for bladder cancer gene therapy, plans 2026 filing (Endpoints)
- Neurocrine reports Phase 2 fail for depression drug it licensed from Takeda (Endpoints)
- Novo Nordisk posts mixed mid-stage data on cardiomyopathy drug with new mechanism (Endpoints)
- Drugmakers Pile Into a Cancer Gold Rush With Questionable Payoff (Bloomberg)
- Neuberg Diagnostics Said to Eye $350 Million India IPO in 2026 (Bloomberg)
- Kezar Loses 70% of Staff After FDA Cancels Meeting on Autoimmune Asset (BioSpace)
- AstraZeneca hits record high, cements lead as UK's biggest stock (Reuters)
- Despite Obesity Drug Pricing Deal, GLP-1 Compounders Continue To Operate in the Shadows (BioSpace)
- Medicare will pay more than $1,000 for AI to analyze a heart scan. Is that too much? (STAT)
- Health IT startup Fabric buys UCM Digital Health — its 5th acquisition in 3 years (Endpoints)
- Can Chatbots Treat Depression? FDA Advisers Urge Caution on Generative AI Tools (MedTech Insight)
- BCI Maker INBRAIN Inks Deal With Microsoft To Explore Agentic AI Use For Monitoring Patients (MedTech Insight)
- Prosthetics: Firms Like Unhindr And Esper Shape Market On the Cusp of Great Change (MedTech Insight)
- Deals Shaping The Medtech And Diagnostics Industries, October 2025 (MedTech Insight)
- TreeHouse Foods to be acquired for $2.9B (Food Dive)
- Salmonella in sprouts sickens 44 in Australia (Food Safety News)
- Australian firm fined for causing botulism illness (Food Safety News)
- Researchers say Listeria biofilms are particularly dangerous (Food Safety News)
- Jury gives Novo Nordisk a win in decade-long hemophilia fraud case (Endpoints)
- Activists Assemble for Big M&A Push in US (Bloomberg)
A story’s inclusion in Regulatory Recon does not imply endorsement by Regulatory Focus or RAPS.
